Use of 20-hete synthesizing enzyme inhibitors as therapy for cerebral vascular diseases

摘要

A method for treating cerebral vascular diseases in a human or non-human animal is disclosed. The method involves inhibiting 20-HETE synthesizing enzyme activity sufficiently to increase or prevent a decrease in cerebral blood flow in the human or non-human animal.